Immune-Boosting vaccine trial offers hope to keep aggressive childhood cancer at bay
NCT ID NCT04936529
Summary
This study is testing whether a combination of a vaccine, an oral sugar supplement (beta-glucan), and an immune-stimulating protein (GM-CSF) can help prevent cancer from coming back in people with high-risk neuroblastoma who are currently in remission. The treatment aims to train and strengthen the body's own immune system to recognize and attack any remaining cancer cells. Researchers are enrolling 286 patients who have completed their initial cancer treatment and have no detectable disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.